BG Medicine, Inc. (BGMD) Reports In-Line Q1 Loss of 8c/Share

BG Medicine, Inc. (NASDAQ: BGMD) reported Q1 EPS of ($0.08), in-line with the analyst estimate of ($0.08). Revenue for the quarter came in at $739 thousand versus the consensus estimate of $1.3 million.

For earnings history and earnings-related data on BG Medicine, Inc. (BGMD) click here.

You May Also Be Interested In

• JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
• Hyperion DeFi (HYPD) Tops Q2 EPS by 57c
• JPMorgan Upgrades Kolmar Korea Co Ltd (161890:KS) to Overweight